Anna Castañé
Grup de recerca
- Neurofarmacologia de sistemes Accredited researcher (R3A-IIBB-CSIC)
Publicacions destacades
-
Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex.
Autors:Referència: NEUROPHARMACOLOGY 2018. -
Differential Patterns of Subcortical Activity Evoked by Glial GLT-1 Blockade in Prelimbic and Infralimbic Cortex: Relationship to Antidepressant-Like Effects in Rats.
Autors:Referència: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 2017. -
Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats.
Autors:Referència: Translational Psychiatry 2017. -
Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS.
Autors:Referència: NATURE REVIEWS DRUG DISCOVERY 2017. -
PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments
Autors:Referència: PSYCHOPHARMACOLOGY 2015. -
5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetine
Autors:Referència: EUROPEAN NEUROPSYCHOPHARMACOLOGY 2015. -
Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects
Autors:Referència: MOLECULAR PSYCHIATRY 2012. -
Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats
Autors:Referència: BEHAVIOURAL BRAIN RESEARCH 2010. -
Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior
Autors:Referència: PSYCHOPHARMACOLOGY 2009. -
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence
Autors:Referència: NEUROPHARMACOLOGY 2002.
